摘要
目的探讨急诊应用胺碘酮治疗冠心病快速心律失常的临床疗效。方法随机抽取2012年10月~2014年10月我院收治的急诊冠心病快速心律失常患者120例,分为观察组与对照组,每组60例,给予对照组患者单纯胺碘酮口服治疗,给予观察组口服联合注射治疗,对比两组治疗后的疗效。结果观察组治疗有效率为95%,明显高于对照组的75.0%,差异明显（P〈0.05）;具有统计学意义;观察组不良反应6例、对照组8例,不良反应率方面差异不明显（P〉0.05）,无统计学意义。结论胺碘酮口服联合注射治疗冠心病快速心律失常疗效显著,且具有很高的安全性,值得在临床治疗中推广使用。
Objective To investigate the clinical efficacy of amiodarone in coronary heart disease （CHD） patients with tachyarrhythmia in the emergency department. Methods A total of 120 CHD patients with tachyarrhythmia admitted to the emergency department of our hospital from October 2012 to October 2014 were randomly selected and divided into observation group （n=60） and control group （n=60）. The control group was orally given amiodarone alone, while the observation group received oral amiodarone and amiodarone injection. The treatment outcomes of the two groups were compared. Results The observation group had a significantly higher response rate than the control group （95% vs 75%, P〈0.05）. Adverse reactions were seen in 6 cases in the observation group and in 8 cases in the control group, without significant difference in the incidence of adverse reactions （P〉0.05）. Conclusion Orally given and injected amindarone has significant efficacy and high safety in CHD patients with tachyarrhythmia and holds promise for use in clinical treatment.
出处
《心血管病防治知识（学术版）》
2015年第5期78-80,共3页
Prevention and Treatment of Cardiovascular Disease
关键词
胺碘酮
冠心病
快速心律失常
疗效观察
Amiodarone
Coronary heart disease
Tachyarrhythmia
Efficacy
